LJL Biosystems’ Private Placement Brings $19 M | GenomeWeb


UNNYVALE, Calif.--LJL BioSystems has entered into purchase agreements for a private placement of 1.76 million shares of common stock at $11 each to new and current investors for approximately $19 million. The company intends to use net proceeds from the private placement for working capital and other general corporate purposes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.